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373depression. To investigate the possible role of
mitochondrial-induced sterile inﬂammation in the co-
occurrence of anxiety and depression, in this study, we trea-
ted adult male mice with the intracerebroventricular (i.c.v.)
infusion of a single low dose of streptozotocin (STZ, 0.2 mg/
mouse). Using valid and qualiﬁed behavioral tests for the
assessment of depressive and anxiety-like behaviors, we
showed that STZ-treated mice exhibited behaviors relevant
to anxiety and depression 24 h following STZ treatment. We
observed that the co-occurrence of anxiety and depressive-
like behaviors in animals were associated with abnormal
mitochondrial function, nitric oxide overproduction and,
the increased activity of cytosolic phospholipase A2 (cPLA2)
in the hippocampus. Further, STZ-treated mice had a signif-
icant upregulation of genes associated with the innate
immune system such as toll-like receptors 2 and 4. Patholog-
ical evaluations showed no sign of neurodegeneration in the
hippocampus of STZ-treated mice. Results of this study
revealed that behavioral abnormalities provoked by STZ, as
a cytotoxic agent that targetsmitochondria and energymeta-
bolism, are associated with abnormal mitochondrial activity
and, consequently the initiation of innate-inﬂammatory
responses in the hippocampus. Our ﬁndings highlight the
role of mitochondria and innate immunity in the formation
of sterile inﬂammation and behaviors relevant to anxiety
and depression. Also, we have shown that STZ injection
(i.c.v.) might be an animal model for depression and
anxiety disorders based on sterile inﬂammation. 2016 IBRO.
Published by Elsevier Ltd. All rights reserved.
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Major depression is a debilitating disorder that is
considered as a health concern in the current century
(Ustun, 2001). Despite the enormous eﬀorts that have
been done to surmount the obstacles, less progress has
been achieved due to treatment or ﬁnding the underlying
mechanisms of depression (Fournier et al., 2010). Recent
evidence indicates the involvement of the immune-
inﬂammatory responses in the pathobiology of depression
(Maes, 2011). A large body of evidence has shown that the
administration of lipopolysaccharide (LPS) is able to acti-
vate toll-like receptor 4 (TLR-4) which, consequently pro-
vokes behavioral abnormalities similar to those observed
in depressed people (Yirmiya, 1996; Reichenberg et al.,
374 S. Amiri et al. / Neuroscience 340 (2017) 373–3832001). Emerging lines of research suggest that NOD-like
receptors, the nucleotide-binding oligomerization domain
(NOD)-like receptors and TLRs are tightly involved in the
pathogenesis of the majority of mental disorders such as
depression (Choi and Ryter, 2014).
Regardless of the ability of invasive pathogens to
stimulate the innate immune system, activation of
immune-inﬂammatory pathways occurs in response to
the cellular stress or damage under sterile conditions.
Sterile inﬂammation is induced as a consequence of
trauma, cellular injury or stress which, occurs in the
absence of any microorganisms. Immuno-inﬂammatory
responses to sterile inﬂammation are accompanied by
the activation of immune cells and the production of pro-
inﬂammatory cytokines and chemokines (Chen and
Nun˜ez, 2010a,b). Incidence of sterile inﬂammation is
highly relevant to impaired energy hemostasis and mito-
chondrial dysfunction. Recent evidence suggests that a
substantial increase in the production of reactive oxygen
species (ROS) (in) directly is implicated in the activation
of immune-inﬂammatory responses through the genera-
tion of damage-associated molecular patterns (DAMPs)
(Gurung et al., 2015). In this context, a growing body of
evidence indicates that mitochondrial dysfunction and
inﬂammatory pathways contribute to the pathobiology of
type 2 Diabetes (T2D), Alzheimer’s disease (AD) and
depression.
Streptozotocin (STZ) is a well-characterized
compound to induce oxidative stress, neuro-
inﬂammation and cellular energy dysfunction (Rai et al.,
2014; Rajasekar et al., 2014). Although STZ has been
widely used for the modeling of diabetes and AD in
rodents, a recent study has revealed that the intracere-
broventricular (i.c.v.) infusion of STZ caused depressive-
like behaviors in mice (Souza et al., 2013b). Considering
the involvement of mitochondrial dysfunction and inﬂam-
mation in the pathogenesis of diabetes, AD and depres-
sion, we assumed that the central administration of STZ
may be a suitable tool to investigate the underlying mech-
anisms involved in the pathophysiology of depression
under sterile conditions. In this regard, we tested whether
(1) i.c.v. administration of STZ is able to provoke behav-
iors related to the anxiety and depression (2) behavioral
changes are associated with mitochondrial dysfunction
in the hippocampus and (3) i.c.v. administration of STZ
is able to alter immune-inﬂammatory factors in the
hippocampus. We investigated the eﬀects of STZ on the
hippocampus because hippocampal formation is highly
involved in the pathophysiology of several neurological
and psychiatric disorders.EXPERIMENTAL PROCEDURES
Animals and treatments
Male NMRI mice weighing 25–30 g were purchased from
the Pasteur Institute, Tehran, Iran. Animals were housed
at the temperature of 21–23 C under a 12 h regular
light/dark cycle with given access to food and water ad
lib. All experiments were performed between 10:00 and
14:00 h. All procedures were performed in accordance
with the NIH Guide for the Care and Use of LaboratoryAnimals which were approved by the Animal Ethics
committee of Zanjan University of Medical Sciences.
Full eﬀorts were made to minimize the use of animals
and to optimize their comfort.
Streptozotocin treatment
Streptozotocin (Sigma, St Louis, MO, USA) was dissolved
in sterile physiological saline (0.9%), and administered to
mice at the dose of 0.2 mg/4 lL/per mouse through i.c.v.
route using a previously reported method by Haley and
McCormick, 1957. Animals were euthanized using pento-
barbital (60 mg/kg, i.p.) after administration of STZ. The
treated animals (STZ groups) were tested 24 h after drug
injection for behavioral or molecular assessments. In
order to exclude the possible eﬀect of i.c.v. saline injec-
tion, animals in the sham group were treated with sterile
saline (4 lL/per mouse, i.c.v. route) and were tested
24 h after saline injection. Dose and the administration
time of STZ were selected based on our pilot studies
and previously published data (Souza et al., 2013b).
Experimental design
Animals were divided into two groups: Sham (treated by
saline) and experimental (treated with STZ). After
treatment with STZ (0.2 mg/4 ll/mouse), the animals
were subjected to the behavioral tests which include
OFT and HBT (n= 6), FST and Splash test (n= 6).
For cellular and molecular experiments, diﬀerent sets of
animals were used in each group. Molecular evaluations
include nitrite assay (n= 6), serum glucose level
(n= 10), cytoplasmic phospholipase A2 (cPLA2) activity
(n= 5), gene expression (n= 4), mitochondrial function
(n= 4) and histopathological evaluation (n= 3). As
reported by previous reports, the in vitro assays used in
this study are highly reproducible and groups of 3–5
animals would suﬃce to obtain reliable results (Amiri
et al., 2015a,b; Sonei et al., 2016).
BEHAVIORAL ASSESSMENTS
Forced swimming test (FST)
In this test, prolongation of immobility time in response to
an inescapable challenge reﬂects the despair behavior in
rodents (Porsolt et al., 1977). In brief, 24 h after the injec-
tion of saline or STZ, animals were placed in cylinders
(10  25 cm, diameter  height) containing 19 cm of
water at 23 ± 1 C for 6 min. The immobility time was
recorded during the last 4 min of the test by a blinded
investigator. A mouse was considered to be immobile
when it remained ﬂoating motionless in the water and
made negligible movements to keep its head above
water.
Splash test
In rodents, motivational and self-care diﬃculties can be
assessed by splash test. In this test, we measured the
grooming behavior of mice which is considered as an
indirect measure of palatable solution intake. A 10%
sucrose solution was squirted on the dorsal coat of
S. Amiri et al. / Neuroscience 340 (2017) 373–383 375animals while they were in their home cages and mice
were videotaped for 5 min. In this test, grooming activity
behaviors include nose/face grooming, head washing,
and body grooming (David et al., 2009; Detanico et al.,
2009; Haj-Mirzaian et al., 2015).
Open-ﬁeld test (OFT)
This test is used as a criterion for the evaluation of motor
function and anxiety-like behaviors (Kulesskaya and
Voikar, 2014). The OFT box was made of Plexiglas
(50 cm  50 cm  40 cm), which was dimly illuminated
during the test. Mice were placed individually on the cor-
ner of the box, and their behaviors were videotaped for
5 min and were analyzed by Ethovision software version
8 (Noldus, Netherlands). Following measures were
assessed in this test; distance moved (horizontal activity),
number of rearings (vertical activity), and time spent in the
central zone (30 cm  30 cm).
Hole-board test (HBT)
Hole-board test is a valid test to assess the anxiety-like
behaviors in rodents (Takeda et al., 1998; Amiri et al.,
2015b). The hole-board apparatus was made of Plexiglas
(50 cm  50 cm) with sixteen equally 3-cm diameter holes
and was placed 50 cm above the ﬂoor. The apparatus
was dimly illuminated (40 lx) and the number of head-
dips of each mouse was counted in a 5-min period by
an experimenter who was blind to treatment conditions.
Reduction in the frequency of head-dips was considered
as anxious behavior of animals.
Serum preparation
The mice were anesthetized (60 pentobarbital mg/kg, i.p.)
to open the heart for the blood collection in test tube.
Then, the test tube was put at 37 C for 30 min to
coagulate the blood. The serum was separated by
centrifugation at 3,500 rpm for 10 min and stored at
80 C until further analysis.
Tissue preparation
Animals were fasted overnight and then sacriﬁced.
Hippocampi were dissected out and stored at 80 C.
The samples were divided into three diﬀerent groups;
ﬁrst set of samples were used for preparation of tissue
homogenate, on which measurement of oxidative stress
parameters, the activity of phospholipase A2 (PLA2) and
nitrite levels were performed. Second set of samples
were used for total RNA extraction. The last set of
samples were ﬁxed in 10% formalin, sectioned, and
stained with hematoxylin and eosin (H&E) for
pathological evaluations.
Mitochondrial preparation
Animals (24 h after saline or STZ injections) were
decapitated and hippocampi were dissected on ice,
immersed in liquid nitrogen and were stored in 80 C
freezer. Homogenization was done at 4 C using cold
mannitol solution medium (Lores-Arnaiz et al., 2010).The homogenate was centrifuged at 1000g for 10 min at
4 C. The supernatant was centrifuged at 10,000g for
10 min as a source of hippocampal mitochondria. The
heavy mitochondrial fraction was collected and re-
suspended in the mannitol solution and, re-centrifuged
twice at 10,000g for 10 min. The resulting pellet (P2 frac-
tion), including both synaptic and non-synaptic mitochon-
dria was re-suspended in desired buﬀer based on
oxidative stress markers including ROS production,
ATP, and glutathione (GSH).
ROS formation
The mitochondrial H2O2 production was assayed by
ﬂowcytometer via incubation of mitochondrial
suspension with 20,70-dichloroﬂuorescein diacetate
(DCFH-DA) (ﬁnal concentration of 10 lM) in respiratory
buﬀer (Gao et al., 2009) using the Flomax software
(equipped with a 488-nm argon ion laser). DCFH-DA
was used as reagent. Fluorescence signals were
obtained using a 530-nm band pass ﬁlter (FL-1 channel)
at least 12,000 counts per sample (Gao et al., 2009;
Hosseini et al., 2014).
ATP levels
ATP level in each sample was measured by applying
luciferase enzyme, and using Sirius tube luminometer
(Berthold Detection System, Germany) as previously
described in our lab (Hosseini et al., 2014).
Glutathione (GSH) levels
Glutathione levels were determined using 5,50-dithiobis-
(2-nitrobenzoic acid) or DTNB reagent. The developed
yellow color was read at 412 nm using a
spectrophotometer (UV-1601 PC, Shimadzu, Japan)
and expressed as lg/mg protein based on calibration
standard curve (Jayakumar et al., 2014).
Nitrite levels
Nitrite levels in the hippocampi were determined by the
Griess method at 540 nm using NaNO2 (Sigma, USA)
for preparation of standard curve. Concentration of
nitrite was normalized to the weight of each sample
(Ding et al., 2010; Kordjazy et al., 2015).
Measurement the activity of cPLA2
Phospholipase A2 activity was measured by a cPLA2
Assay Kit (Cayman chemical, Michigan, USA) and was
reported as nano mol/min/mg protein (Nikoui et al., 2015).
Real time RT-PCR
Total RNA was extracted from hippocampi using TRIzol
reagent (Invitrogen). Alterations in mRNA levels of
selected genes were measured by qRT-PCR following
reverse transcription of 1 lg of RNA from each sample
using PrimeScript RT reagent kit (Takara Bio, Inc.,
Otsu, Japan). qRT-PCR was performed on a light cycler
instrument (Roche Diagnostics, Mannheim, Germany)
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Thermal cycling conditions consisted of an initial
activation step for 30 s at 95 C followed by 45 cycles
including a denaturation step for 5 s at 95 C and a
combined annealing/extension step for 20 s at 60 C.
Melting curve analysis was applied to validate whether
all primers yielded a single PCR product. The genes
and their used primers are listed in Table 1.
Hypoxanthine phosphoribosyl transferase1 (hprt1) was
ampliﬁed as normalizer and the fold change in the
expression of each target mRNA relative to hprt1 was
calculated on the basis of 2-DDct relative expression
formulas.Microscopy
Animals (n= 4) were euthanized under anesthesia using
pentobarbital (60 mg/kg,i.p.), 24 h after STZ injection.
Trans-cardiac perfusion was performed via 0.9% normal
saline ﬁrst and then continued with ice-cold 4%
paraformaldehyde in 0.1Mphosphate buﬀer (pH 7.5).
Then, the brain was isolated. After ﬁxation, the brain
tissues were immersed in 10% formalin. Formalin-ﬁxed
brains were paraﬃn-embedded and 5 lm sections were
obtained. Five sections obtained from each brain and
were deparaﬃnized using xylene and stained with H&E.
Histological analysis was performed under light
microscopy (400; Olympus microscope) after preparing
images under objective lens using a digital camera
(Olympus, Japan) and displayed on a computer monitor.
Three ﬁelds from each slide were selected and the
density of dark neurons and normal neurons within the
pyramidal cell layer of both CA1 and CA3 areas was
estimated in each ﬁeld. In histological studies dark
neurons are recognized by hyperbasophilia property as
a type of cell degeneration (Zsombok et al., 2005). The
relation of normal neurons to normal neurons +dark neu-
rons (total number of neurons) was evaluated in each
group. The ﬁelds were randomly selected. Moreover,
the maximum and minimum nucleus diameter was mea-
sured and the average of the measurements was
reported for each group. The thickness of pyramidal cell
layer of CA1 and CA3 areas was measured. The linear
measurements were performed at determinate points
along the CA1 and CA3 subﬁelds. All measurements were
performed using Image J software by a blinded
pathologist.Table 1. Primers
Gene
Forward
Il-6 CTGCAAGAGACTTCCATCCAG
Il-1b GAAATGCCACCTTTTGACAGTG
TNF-a CTGAACTTCGGGGTGATCGG
Hprt1 TGCTCGAGATGTGATGAAGG
Myd88 ATCGCTGTTCTTGAACCCTCG
Tlr-2 CTCTTCAGCAAACGCTGTTCT
Tlr-4 ATGGCATGGCTTACACCACC
Nlrp3 ATCAACAGGCGAGACCTCTGGlucose levels
Serum glucose concentrations were measured either
before the injection of STZ or diﬀerent time intervals
after STZ (i.c.v.) injections (6 h, 24 h, and 48 h). Each
animal was decapitated under mild anesthesia using
pentobarbital (60 mg/kg, i.p.) and the blood was
collected. Serum glucose concentrations were
measured by the glucose oxidase method (Glucose
Analyzer II, Beck-man).Protein assay
We used Coomassie blue protein-binding method by
using BSA as the standard for measuring the
mitochondrial protein levels (Bradford, 1976). To keep
the uniformity of experimental condition, the mitochondrial
samples (100 lg /ml mitochondrial protein) were used in
all experiments.Statistics
The sample size was calculated by power calculations
using G power software (ver.3.1.7, Franz Faul,
Universitat Kiel, Germany). We set a error at 0.05 and
power (1-b) at 0.8 and the required total sample size
per group was calculated as 6–8 in behavioral tests and
3–6 in molecular studies. Comparison between the
groups was analyzed using t-test and a one-way
analysis of variance (ANOVA) followed by tukey’s post
hoc tests using the Graph-pad prism software (version
6). P< 0.05 was considered statistically signiﬁcant.RESULTS
Administration of STZ provoked behaviors
associated with depression and anxiety in mice
Analyses revealed that i.c.v. administration of STZ
provoked behaviors relevant to depression and anxiety
in male adult mice. We demonstrated the impact of STZ
injection on diﬀerent aspects of depressive-like
behaviors such as despair behavior and deﬁcit in
motivation using FST and splash test. The t-test
analysis results showed that the immobility time was
increased in STZ-treated animals when compared with
sham group in the FST (t= 6.152, df= 10, P< 0.001,
Fig. 1a). Also, STZ treatment caused a signiﬁcant
reduction in grooming activity time in the splash testSequence (50 ? 30)
Reverse
AGTGGTATAGACAGGTCTGTTGG
TGGATGCTCTCATCAGGACAG
GGCTTGTCACTCGAATTTTGAGA
AAGCAGATGGCCACAGAACT
CTCACGGTCTAACAAGGCCAG
GGCGTCTCCCTCTATTGTATTG
GAGGCCAATTTTGTCTCCACA
GTCCTCCTGGCATACCATAGA
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P< 0.001, Fig. 1b).
The possible eﬀect of STZ injection on locomotor
activity and anxiety-like behaviors was determined using
OFT and HBT. In the OFT, t-test analyses revealed that
there is no signiﬁcant diﬀerence in the total distance
moved (horizontal activity) (t= 0.1117, df= 10,
P> 0.05, Fig. 1c) and number of rearings (vertical
activity) (t= 0.0571, df= 10, P> 0.05, Fig. 1d)
between treated groups. As shown in Fig. 1e, f,
analyses demonstrated that there were signiﬁcant
diﬀerences in time spent in the central zone in OFT
(t= 5.320, df= 10, P< 0.001, Fig. 1e) and number ofFig. 1. Eﬀect of intracerebroventricular STZ administration on behaviors relat
anxiety and locomotor activity. Eﬀect of STZ (0.2 mg/4 lL/mouse) (STZ
(4 lL/mouse) (Sham group) intracerebroventricular injections on the immob
(A), grooming activity time in the splash test (B), total distance moved in the
rearings in the OFT (D), time spent in the central zone in the OFT (E), and nu
the HBT (F). Values are expressed as mean ± S.E.M. and were analyzed us
compared with the sham group in each ﬁgure.head-dips in the HBT (t= 4.503, df= 10, P< 0.001,
Fig. 1f) between sham and STZ-treated groups. Also,
we observed that STZ-treated animals exhibited
behavioral abnormalities for more than 21 days after
STZ injection.Serum glucose level
In comparison with sham groups, one-way ANOVA
analysis followed by tukey’s post test revealed that
there was no signiﬁcant diﬀerence in serum glucose
level between 6, 24 and 48 h time intervals after STZ
administration (Data not Shown).ed to depression and
group) and saline
ility time in the FST
OFT (C), number of
mber of head-dips in
ing t-test. *P< 0.05STZ increased cPLA2 activity and
increased the expression of genes
relevant to immune-inﬂammatory
system in the hippocampus
Fig. 3 shows the eﬀects of STZ on the
genes relevant to immune-
inﬂammatory pathways. In
comparison with the sham group, t-
test analysis demonstrated the up-
regulation of Tlr-2 (t= 3.150, df= 6,
P< 0.05), Tlr-4 (t= 2.642, df= 6,
P< 0.05), Myd88 (t= 2.713,
df= 6, P< 0.05), Il-6 (t= 4.176,
df= 6, P< 0.01), and Nlrp-3
(t= 10.55, df= 6, P< 0.001) in the
hippocampus of STZ-treated mice. In
addition, we observed no signiﬁcant
diﬀerences in the expression of Il-1ß
(t= 0.1639, df= 6, P> 0.05) and
Tnf-a (t= 0.1414, df= 6, P> 0.05)
in STZ-treated mice when compared
with sham mice. In addition, there
was no signiﬁcant eﬀect of treatments
(STZ vs. saline) on Hprt1 expression.
Further, our results showed a
signiﬁcant eﬀect of STZ treatment on
cPLA2 activity in the hippocampus.
In this regard, t-test analysis
revealed that there was a signiﬁcant
diﬀerence in cPLA2 activity between
saline and STZ-treated groups
(t= 7.753, df= 8, P< 0.001,
Fig. 4). Further, as shown in Fig. 4,
tukey’s analyses revealed that cPLA2
had a higher activity in the
hippocampal tissue of STZ-treated
animals when compared with sham
mice (P< 0.001).STZ aﬀected hippocampal
mitochondria function and induced
nitrosative stress
The eﬀects of STZ treatment on
hippocampal mitochondrial GSH,
ATP and nitrite levels are presented
in Table 2. Results obtained from a
Fig. 2. Eﬀects of intracerebroventricular STZ administration on ROS formation in the hippocam-
pus. The ROS in each sample was read with 485 nm excitation and 520 nm emission using a
ﬂuorimeter after 5, 15, 30, and 60 min in Sham (received saline i.c.v.) and STZ treated (STZ group)
animals. The signs for increased ROS formation in ﬂowcytograms are shifting the ROS peak to the
right and increasing of AUC.
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signiﬁcant diﬀerence in GSH, ATP, and nitrite levels
between groups. Further, tukey’s analyses revealed
signiﬁcant decrease in GSH (P< 0.001), ATP
(P< 0.001), and nitrite levels (P< 0.001) in STZ-
treated mice as compared to sham groups.
Moreover, the assessment of ROS formation was
performed in 4 time intervals (5 min, 15 min, 30 min, and
60 min) in STZ-treated and sham groups (Fig. 2).
Increased mitochondrial ROS formation in
ﬂowcytograms is presented as shifting the ROS peak to
the rightward not just increased AUC. As shown in
Fig. 2, in comparison to sham, there is a signiﬁcant
rightward shift of DCF peak (concentration dependent)
in the hippocampus of STZ-treated groupFig. 3. Eﬀect of intracerebroventricular STZ administration on
hippocampal immune-inﬂammatory markers. Eﬀect of intracere-
broventricular saline (Sham group) and STZ (STZ group) injections
on Tnf-a, IL-1b, Il-6, Nlrp-3, Tlr-4, Tlr-2 and Myd88 gene expressions
in the hippocampus of the animals, Values are expressed as mean
± S.E.M. and were analyzed using t-test. *P< 0.05 compared with
the sham group in each coupled columns.
Fig. 4. Eﬀect of intr
hippocampal cPLA2 a
(Sham group) and ST
(nmol/min/mg protein),
were analyzed using
group.
Table 2. Eﬀect of intra
mice) on GSH, ATP, an
expressed as Mean ± S
followed by tukey’s po
group
lg GSH/mg
protein
Sham 13.9 ± 3.4
STZ 4.47 ± 1.9*STZ did not induce hippocampal
damage in histopathological
studies
Our histopathological evaluation after
the experimental period showed no
signiﬁcant diﬀerence between sham
and STZ treated groups in the
number of neurons at the CA1 and
CA3 panels of hippocampus. The
results of STZ injection in the CA1
panel of hippocampus showed some
reduction in neuronal density
(neuronal drop-out), although this
diﬀerence was not signiﬁcant.
Twenty-four hours following STZ
injection, we observed no signiﬁcant
diﬀerences between the groups in
the normal/all pyramidal neurons
ratios in the CA1 and CA3 areas as
well as diameters of the CA1 and
CA3 areas of hippocampus
(P> 0.05, Fig. 5). Moreover, there
was signiﬁcant diﬀerence in the
nuclear diameter of pyramidal cellsin the CA1 and CA3 area between sham and STZ
groups (P< 0.05, Fig. 5).DISCUSSION
In the current study, we found that negative aﬀective
behaviors following the administration of STZacerebroventricular STZ administration on
ctivity. Eﬀect of intracerebroventricular saline
Z (STZ group) injections on cPLA2 activity
Values are expressed as mean ± S.E.M. and
t-test. *P< 0.001 compared with the sham
cerebroventricular STZ administration (0.2 mg/
d nitrite level in the hippocampus: Values are
.D. and were analyzed using one-way ANOVA
st hoc tests *P< 0.001 compared with Sham
nmol ATP/mg
protein
nmol Nitrite/mg
tissue
2.12 ± 0.23 81.3 ± 5
1.39 ± 0.16* 129.6 ± 4.6*
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the mitochondrial function, oxidative challenge, and
immune-inﬂammatory responses in the hippocampus of
mice.
Using rodent models of STZ-induced diabetes/AD,
several investigations have shown that depressive
behaviors in STZ-treated rodents are associated with
oxidative challenge and neurochemical changes in the
hippocampus (Haider et al., 2013; de Morais et al.,
2014; Lee et al., 2015). By using FST, as a cogent behav-
ioral test for the evaluation of passive behaviors in mice,
we observed a signiﬁcant increase in the immobility time
of STZ-treated mice after 24 h. The increase in immobility
time reﬂects the behavioral despair in humans as a core
symptom of depression (Cryan and Holmes, 2005). In
addition, the results of splash test indicate the presence
of motivational and self-care diﬃculties in animals 24 h
following STZ administration. The decrease in grooming
activity time in response to 10% sucrose is considered
as a behavioral measure for assessing motivation and
self-care deﬁcits in both mice and rats (David et al.,
2009; Marrocco et al., 2014). Furthermore, STZ produced
anxiety-like behaviors in mice subjected to HBT and OFT.
In this context, STZ-treated mice exhibited a remarkable
decline in the number of head-dips in HBT, and avoidance
to enter the central zone of OFT. This behavioral proﬁle
suggests that STZ is able to induce anxiety-like behaviors
in mice as the most prevalent comorbid condition
observed in depressed patients. In this context, our ﬁnd-
ings are in agreement with those studies which have
reported that behavioral abnormalities in mice treated with
STZ (i.c.v.) are associated with increased inﬂammation in
the brain (Souza et al., 2013b; Ho et al., 2014).
Clinical and preclinical studies indicate that
depression either as a comorbid condition in a systemic
disease or as a result of exposure to chronic stress
correlates with inﬂammation (Slavich and Irwin, 2014). It
has been evident that depression can occur following
speciﬁc medical conditions such as stroke, stimulants
withdrawal, PTSD, and traumatic brain injury (Barr
et al., 2002; Caeiro et al., 2006; Gill et al., 2009). In addi-
tion, single-dose administration of LPS is known to pro-
duce depressive-like behaviors in animals after 24 h,
and it is used as a valid animal model of depression
(Souza et al., 2013a). Furthermore, besides pathogen-
induced inﬂammation, sterile inﬂammation has also been
involved in the development of mood disorders (Anisman,
2009; Walker, 2013). Similar to LPS studies, we used
STZ to investigate the role of sterile inﬂammation (versus
microbial-dependent inﬂammation) 24 h following STZ
administration. It is important to note that animals in our
study were under anesthesia during administration of
STZ and they experienced no acute stress.
Emerging lines of evidence suggests that
mitochondrial dysfunction is the triggering factor for the
development of the majority of brain disorders such as
depression (Gardner and Boles, 2011; Morava and
Kozicz, 2013). In this context, evidence is accumulating
to show that STZ is able to induce mitochondrial dysfunc-
tion, energy challenge, and inﬂammatory responses in the
brain (Chen et al., 2013; Rajasekar et al., 2014). Ourresults revealed that energy hemostasis and redox state
dramatically underwent negative changes in the hip-
pocampus of STZ-treated mice. A massive production of
ROS and NO, and decreased levels of ATP and GSH pre-
sent a picture in which energy metabolism and antioxidant
system undergo negative changes in the hippocampus of
mice 24 h after STZ treatment. Previous studies have
demonstrated that mitochondrial ROS contributes to cel-
lular damage, and these deleterious eﬀects are more sev-
ere when GSH (the main antioxidant of the brain)
depletion occurs (Hosseini et al., 2014; Gawryluk et al.,
2011). Additionally, the increased levels of nitrite in the
hippocampus of STZ-treated mice suggest the involve-
ment of NO overproduction in the initiation of sterile
inﬂammation. Under pathologic conditions, inducible nitric
oxide synthase (iNOS) produces NO which not only aug-
ments the injurious eﬀects of ROS through the formation
of peroxynitrite radicals, but harmfully aﬀects mitochon-
drial function and energy metabolism (Brown, 2001; Liu
et al., 2002). In addition, nitrergic system plays an impor-
tant part in the pathobiology of psychiatric disorders such
as anxiety and depression (Chen et al., 2015; Amiri et al.,
2015a). In the current study, we found a considerable
increase in cPLA2 activity in the hippocampus of STZ-
treated mice. The increased activity of cPLA2 triggers
several inﬂammatory signaling cascades such as
cyclooxygenase and lipoxygenase pathways and harms
intracellular structures such as lysosomes. Since cPLA2
is a calcium-dependent enzyme, the increased activity
of cPLA2 in the hippocampus not only conﬁrms the ele-
vated levels of Ca2+, but also corroborates the activation
of inﬂammatory signaling in the hippocampus of STZ-
treated mice. In this regard, previous studies have shown
that cPLA2 mediates a variety of oxidative and inﬂamma-
tory pathways in the brain following acute exposure to
immune challenge, and adversely aﬀects animal behav-
iors (Sun et al., 2010; Hermann et al., 2013). Finally, all
these molecular changes result in energy and redox chal-
lenge in the cells which consequently lead to the forma-
tion of cellular injury and stress (Festjens et al., 2006).
Recent evidence suggests that under sterile
inﬂammatory conditions, DAMPs and ROS are key
triggers for innate immunity responses (Kang et al.,
2014; Choi et al., 2015). In this regard, DAMPs have been
demonstrated as endogenous ligands for the activation of
TLRs (Fleshner, 2013; Lucas and Maes, 2013). Once
activated, TLRs (mainly TLR-2 and TLR-4) initiate several
intracellular signaling pathways which are associated with
the upregulation of inﬂammatory factors such as NF-jB
(nuclear factor kappa-light-chain-enhancer of activated
B cells) MyD88, IL-6, and iNOS. On the other hand,
mitochondrial-derived ROS not only engages in DAMPs
production through oxidizing intracellular components,
but is able to activate NLRP3 inﬂammasome formation
(Chen and Nun˜ez, 2010a,b; West et al., 2011). Our
results demonstrated that STZ is able to induce a signiﬁ-
cant increase in Myd88 (main player in sterile inﬂamma-
tion) as well as its upstream (Tlr-2 and Tlr-4 as the main
TLRs in sterile inﬂammation) and downstream (Il-6)
expression (Kono et al., 2014). In addition, the over-
expression of Nlrp3 and other innate-immunity compo-
Fig. 5. The eﬀects of STZ injection on hippocampal CA1 and CA3 areas 24 h after injection in
NMRI mice, (A): Representative hematoxylin and eosin (H&E) stained slides from CA1 and CA3
areas (400). (B and C): Nuclear diameter of pyramidal neurons in the CA1 and CA3 areas. (D
and E): Normal/all pyramidal neurons ratio CA1 and CA3 areas. (F and G): Mean diameter of the
CA1 and CA3 areas between sham and STZ groups.
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suggest the possible role of these fac-
tors in the development of the
aﬀective-like behaviors through ster-
ile inﬂammation. Further, these
results indicate that mitochondrial
dysfunction and oxidative challenge
are associated with initiation of
inﬂammatory responses following
STZ treatment. Interestingly, we
observed no alteration in the mRNA
expression of Il-1b 24 h following
STZ injection. To explain the latter
observation, a recent study on throm-
boembolic stroke in mice has shown
that the activation of IL-1b occurs
24 h after the insult (Abulaﬁa et al.,
2009). The expression and activation
of IL-1b is highly dependent to a vari-
ety of factors such as severity, nature
and duration of DAMPs exposure. For
example, the cleavage of pro-IL-1b by
caspase-1 does not occur without the
primary stimulation of microglia
(Brough et al., 2011; Kono et al.,
2014). In comparison with throm-
boembolic stroke, we induced a com-
paratively less severe sterile
inﬂammation in our study. Interest-
ingly, the results of histological
assessment revealed no sign of neu-
rodegeneration in the hippocampus
of STZ-treated mice indicating that
aﬀective-like behaviors of animals
were not associated with neurode-
generation. Using STZ-induced
dementia, a recent study by Kraska
et al. revealed that low dose STZ
(1 mg, icv) induces moderate inﬂam-
mation and neuronal loss after
3 months (Kraska et al., 2012). In this
study, we applied a comparatively low
dose of STZ (0.2 mg, icv) to mice and
also, we evaluated the STZ-induced
eﬀects 24 h following treatments.
Thus, unchanged expression of Il-1b
may be associated with the low inten-
sity of the insult by the low dose STZ.
Examples of such conditions are
behavioral abnormalities following an
ischemic challenge such as stroke
and traumatic brain injury.
Interestingly, recent evidence
indicates that inﬂammasomes and
mitochondrial dysfunction are of
main etiological factors for the
development of metabolic disorders
and their behavioral comorbidities
(Choi and Ryter, 2014; Peeri and
Amiri, 2015). Since STZ has been
long used in the modeling of experi-
S. Amiri et al. / Neuroscience 340 (2017) 373–383 381mental diabetes and AD and recently depression in ani-
mals, our results suggest that similar mechanisms may
play a part in the pathophysiology of other metabolic dis-
orders such as diabetes and AD. In addition, one of the
limitations of this study is that we did not measure the
activity of stress axis. Dysfunction of hypothalamic–pitui
tary–adrenal (HPA) axis is known as the main contributor
in the pathophysiology of depression, and chronic expo-
sure to glucocorticoids leads to the development of
depression. However, even if HPA axis had a severe
response to STZ challenge, acute increase in glucocorti-
coids would not be the main factor responsible for the
emergence of anxiety and mood disorders in animals. It
is important to note that the acute eﬀects of glucocorti-
coids are not associated with depressive and anxiety-
like behaviors and only chronic exposure to glucocorti-
coids has been reported as a risk factor for the develop-
ment of depression (McEwen, 2004, 2005). In addition,
an interesting clinical study by Miller et al. has revealed
that depressive episodes following acute stress are asso-
ciated with inﬂammatory factors and not glucocorticoids
(Miller et al., 2005). Another limitation of this study is that
we did not evaluate the eﬀects of STZ on female mice. In
our future studies, we decide to evaluate the eﬀects of
STZ in female mice to see how hormonal changes during
diﬀerent cycles of estrus cycle may alter the behavioral
and molecular responses of animals. Finally, this proce-
dure could be used as an animal model for sterile
inﬂammation-induced behavioral abnormalities. Such
conditions are observed following traumatic brain injury
and stroke. However, it is now well determined that corti-
costeroids and chronic stress are key factors which con-
tribute to the pathophysiology of depression. Thus, this
animal model is not an appropriate model for evaluating
the pathophysiology of depression after exposure to
social/environmental stressors.
Furthermore, although STZ is not able to transfer
blood brain barrier, we also measured the blood glucose
levels in order to show that STZ has no eﬀect on
peripheral metabolism state after 24 h. We also
evaluated the eﬀects of acute administration of ﬂuoxetine
and aminoguanidine (iNOS inhibitor) 24 h following STZ
treatment. We observed that these treatments could
eﬀectively reverse the behavioral abnormalities and
mitochondrial dysfunction in the hippocampus of mice
indicating that inﬂammatory responses are involved in
the emergence of behavioral abnormalities following
sterile inﬂammation (data not shown).CONCLUSION
Overall, results of this work provided evidence that
aﬀective-like behaviors in mice following single
administration of low dose STZ into lateral ventricles are
associated with negative changes in mitochondrial
function and inﬂammatory status in the hippocampus,
and these factors at least in part are associated with the
appearance of behavioral deﬁcits 24 h following STZ
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